LETTERS TO THE EDITOR
low dopamine neurotransmission. This keeps prolactin levels
However, as I argued in detail in my recent book (2), family,
normal, spares cognition, and obviates extrapyramidal signs.
twin, and adoption studies do indeed suffer from "strong and
This letter provides data on the off-rates of additional
consistent methodologic biases operating across study de-
newer atypical antipsychotics, using methods similar to those
signs," not the least of which is the twin method's question-
ture cells (1, 2) and drug concentrations found in the spinal
Dr. Kendler noted that the "low" replication level for link-
fluid of patients (4). The times for 50% dissociation from D
age findings "contrasts strikingly with the high level of consis-
were the following: 42 seconds for 4 nM S-(-)-amisulpride, 66
tency seen in the results of genetic epidemiologic studies-
seconds for 40 nM amoxapine, 52 seconds for 10 nM aripipra-
for example, the results of family and twin studies of schizo-
zole, 30 minutes for 1.5 nM chlorpromazine, 15 seconds for
phrenia" (p. 7). In fact, there is no "striking contrast" between
200 nM clozapine, 38 seconds for 1 nM domperidone, 38 min-
these results if they are viewed as evidence supporting a
utes for 2 nM haloperidol, 16 minutes for 20 nM loxapine, 17
purely environmental etiology for psychiatric disorders. Envi-
minutes for 5 nM olanzapine, 24 seconds for 140 nM perlap-
ronmental theories predict 1) familial clustering, 2) a higher
ine, 16 seconds for 200 nM quetiapine, 23 minutes for 4 nM
concordance of identical versus fraternal twins, and 3) a fail-
raclopride, 13 seconds for 5 nM remoxipride, 27 minutes for 2
ure to find genes, and this is what we find (2, 3). Rather than
nM risperidone, and 60 seconds for 2 nM paliperidone (9-hy-
consider a purely environmental explanation as a competing
paradigm, Dr. Kendler argued that linkage and association
The data for the rapidly dissociating antipsychotics (amox-
studies cannot be used to test "whether a twin or adoption
apine, aripiprazole, clozapine, perlapine, quetiapine, remox-
study was correct in its conclusion that disorder X is herita-
ipride, and paliperidone) are compatible with their low ex-
ble" (p. 8). I agree, but negative results could at least compel
trapyramidal signs. The extent of risperidone-associated
researchers to take a second look at these methods. Although
extrapyramidal signs may depend on the proportions of ris-
Dr. Kendler views his four strategies as "competing para-
peridone and its metabolite, paliperidone, in the patient.
digms," all four are components of the same biological/ge-
netic paradigm, in contrast to what we might call the "envi-
dose-dependent incidence of extrapyramidal signs; however,
ronment/treatment/stress" paradigm.
the potent anticholinergic action of olanzapine (its dissocia-
Finally, Dr. Kendler called for integrating his four "para-
tion constant of 2.1 nM matches that of benztropine at the
digms," which would "require an appreciation of the comple-
muscarinic receptor) provides an effective anti-extrapyrami-
mentary sources of information obtained by genetic epidemi-
ologic and gene identification approaches" (p. 9). Thus, a"striking contrast" was transformed into "complimentary
References
sources of information" in the space of three pages. Dr. Ken-
1. Seeman P: Atypical antipsychotics: mechanism of action. Can J
dler called his synthesis "explanatory pluralism" (p. 10), but
what this means in practice is falling back on family, twin, and
2. Seeman P, Tallerico T: Rapid release of antipsychotic drugs
adoption results to explain the unexpected failure to find
from dopamine D2 receptors: an explanation for low receptor
genes. Far better, in my view, would be a reexamination of the
occupancy and early clinical relapse upon withdrawal of clo-
assumptions and biases of twin and adoption studies (Dr.
zapine or quetiapine. Am J Psychiatry 1999; 156:876-884
Kendler's paradigms 1 and 2) in the context of considering the
3. Kapur S, Seeman P: Does fast dissociation from the dopamine
possibility that genes for the major psychiatric disorders do
D2 receptor explain the action of atypical antipsychotics? a
new hypothesis. Am J Psychiatry 2001; 158:360-369
References
4. Seeman P, Corbett R, Van Tol HHM: Atypical neuroleptics have
low affinity for dopamine D2 receptors or are selective for D4.
1. Kendler KS: Psychiatric genetics: a methodologic critique. Am J
Neuropsychopharmacology 1997; 16:93-110
2. Joseph J: The Gene Illusion: Genetic Research in Psychiatry and
Psychology Under the Microscope, North American ed. New
York, Algora, 2004 (Ross-on-Wye, UK, PCCS Books, 2003)
3. Joseph J: The Missing Gene: Psychiatry, Heredity, and the Fruit-
Research Paradigms of Psychiatric Genetics
less Search for Genes. New York, Algora (in press)
TO THE EDITOR: In his article, Kenneth S. Kendler, M.D. (1), iden-
tified "four major research paradigms," consisting of 1) "basicgenetic epidemiology," 2) "advanced genetic epidemiology,"
Dr. Kendler Replies
3) "gene finding methods," and 4) "molecular genetics." Dr. Kendler argued that although "a substantial portion" of gene
TO THE EDITOR: In this brief letter, I cannot respond fully to the
association claims "do not survive the test of replication," fam-
issues raised by Dr. Joseph or provide detailed references to
ily, twin, and adoption studies have found "genetic risk fac-
support my position. Dr. Joseph and I disagree in four ways in
tors… for every psychiatric and drug use disorder that has ever
the interpretation of the accumulating literature in psychiat-
been the subject of serious study" (p. 6). Moreover, "Unless
ric genetics. First, in examining family twin and adoption
there are strong and consistent methodologic biases operating
studies of the major psychiatric disorders, I concluded in my
across study designs, this growing body of work indicates that
article that the evidence strongly supports the hypothesis that
genetic risk factors are of substantial etiologic importance for
genetic factors play a significant role in the etiology of these
all major psychiatric and drug use disorders" (p. 6).
conditions. I did not assert that individual studies are free
Am J Psychiatry 162:10, October 2005LETTERS TO THE EDITOR
from methodologic problems. Indeed, in studying human
that humans would be the only species whose behavior is un-
populations by observational means, there can be no such
related to our genetic makeup? It is one thing to criticize the
thing as a perfect study. However, in examining the studies
methodology of specific studies. It is quite another to suggest,
carefully and knowing-for example, that twin and adoption
as Dr. Joseph does, that we reject the results of an entire field
studies have different potential biases but reach the same
of scientific inquiry. This might have been warranted for some
conclusion for the disorders in which both methods have
pseudoscientific systems, such as astrology, alchemy, and the
been used-it becomes very unlikely that the pattern of ob-
Ptolemaic astronomic system. It is highly unlikely that mod-
served results could have arisen from methodological biases
ern psychiatric genetics will be judged by future historians of
Second, Dr. Joseph is concerned about the equal-environ-
References
ment assumption as a significant bias in twin studies. I sharehis concern, but the equal-environment assumption has
1. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I,
been examined in a number of empirical studies. Although
Williams NM, Schwab SG, Pulver AE, Faraone SV, BrzustowiczLM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H,
there is a bit of evidence that this bias might be operative in
Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R,
some disorders, studies that have corrected for its effects typ-
O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist
ically find only small changes in heritability estimates. Al-
J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier
though the equal-environment assumption is probably not
W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman
perfectly true, evidence to date strongly suggests that the bi-
JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-
ases introduced thereby are quite modest.
Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G,
Third, Dr. Joseph argues that current efforts at gene finding
McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E,
for psychiatric disorders have been unsuccessful. Although
Zoega T, Helgason T: Genome scan meta-analysis of schizo-
there certainly have been problems with replication, I dis-
phrenia and bipolar disorder, part II: schizophrenia. Am J Hum
agree with his interpretation. For example, a recent well-
done meta-analysis of schizophrenia linkage studies identi-
2. Owen MJ, Williams NM, O'Donovan MC: The molecular genetics
of schizophrenia: new findings promise new insights. Mol Psy-
fied a number of genomic regions with substantial cross-
study agreement (1). Several susceptibility genes for schizo-
3. Kendler KS: Schizophrenia genetics and dysbindin: a corner
phrenia are beginning to be replicated at rates that are hard
turned? (editorial). Am J Psychiatry 2004; 161:1533-1536
to explain if the original findings were false positive (2). I re-
4. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata
cently summarized this evidence for dysbindin in the Journal
N, Ozaki N, Taguchi T, Tatsumi M, Kamijima K, Straub RE, Wein-
(3), and since then, two further positive reports have been
berger DR, Kunugi H, Hashimoto R: Evidence of novel neuronal
functions of dysbindin, a susceptibility gene for schizophrenia.
Fourth, unlike Dr. Joseph, I judged that it is a priori likely
that genes do contribute to variation in human behavior and
5. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM,
the risk for psychiatric disorders. Behavior is instantiated in
Kucherlapati R, Malhotra AK: Association of the DTNBP1 locus
our brains, which are the product of evolution. The evidence
with schizophrenia in a US population. Am J Hum Genet 2004;
that genetic factors influence behavior in other animals is
overwhelming. As Darwin recognized, behavior is as much
the subject of evolution as physical traits. Is it really plausible
Reprints are not available; however, Letters to the Editor can be downloaded at http://ajp.psychiatryonline.org.Am J Psychiatry 162:10, October 2005
Canterbury Health Research Conference Friday Venue: Christchurch School of Medicine & Health Sciences, Riccarton Ave Saturday venue: Chateau on the Park, 189 Deans Ave Preliminary Program Day One : Friday 26 August, Christchurch School of Medicine & Health Sciences Time Event Location Details “Corticotropin releasing factor (CRF) & urocortin recep
Medication Pocket Guide for Emory Members Please bring this guide with you on your next doctor visit. Medco manages your prescription drug benefit for your health plan. UNDERSTANDING YOUR PLAN The Emory Plan uses a drug formulary, which is a list of medications that are covered under this prescription drug plan. The drug formulary is reviewed by your plan to ensure it includes med- icat